Purification, localization, and expression of human intestinal alkaline sphingomyelinase

Journal of Lipid Research

Volumn 44, Issue 6, 2003, Pages 1241-1250

  Duan, Rui Dong ^a   Cheng, Yajun ^a   Hansen, Gert ^b   Hertervig, Erik ^c   Liu, Jian Jun ^a   Syk, Ingvar ^c   Sjöström, Hans ^b   Nilsson, Åke ^c  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Apoptosis; Colon cancer; Proliferation; Sphingolipid

Indexed keywords

ALKALINE SPHINGOMYELINASE; INTESTINE ENZYME; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CHROMATOGRAPHY; COLON CANCER; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; DOWN REGULATION; ENDOSOME; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME PURIFICATION; GOLGI COMPLEX; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROLYSIS; IMMUNOGOLD ELECTRON MICROSCOPY; INTESTINE CELL; INTESTINE MUCOSA; INTESTINE VILLUS; ISOELECTRIC POINT; MOLECULAR WEIGHT; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; CELL DIVISION; COLONIC NEOPLASMS; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENTEROCYTES; HUMANS; INTESTINAL MUCOSA; INTESTINES; ISOELECTRIC FOCUSING; MOLECULAR WEIGHT; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELINS; TUMOR CELLS, CULTURED;

EID: 0141428125     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M300037-JLR200     Document Type: Article

References (42)

1. Hannun, Y. A., and C. M. Linardic. 1993. Sphingolipid breakdown products: anti-proliferative and tumor-suppressor lipids. Biochim. Biophys. Acta. 1154: 223-236.
2. Merrill, A. H., E. M. Schmelz, E. Wang, D. L. Dillehay, L. G. Rice, F. Meredith, and R. T. Riley. 1997. Importance of sphingolipids and inhibitors of sphingolipid metabolism as components of animal diets. J. Nutr. 127: 830S-833S.
3. Kolesnick, R. N., and M. Kronke. 1998. Regulation of ceramide production and apoptosis. Annu. Rev. Physiol. 60: 643-665.
4. Duan, R-D. 1998. Hydrolysis of sphingomyelin in the gut and clinical implications in colorectal tumorigenesis and other gastrointestinal diseases. Scand. J. Gastroenterol. 33: 673-683.
5. Brasitus, T. A., P. K. Dudeja, and R. Dahiya. 1986. Premalignant alterations in the lipid composition and fluidity of colonic brush border membranes of rats administered 1,2 dimethylhydrazine. J. Clin. Invest. 77: 831-840.
6. Dillehay, D. L., S. K. Webb, E-M. Schmelz, and A. H. Merrill. 1994. Dietary sphingomyelin inhibits 1,2-dimethylhydrazine-induced colon cancer in CF1 mice. J. Nutr. 124: 615-620.
7. Schmelz, E. M., D. L. Dillehay, S. K. Webb, A. Reiter, J. Adams, and A. H. Merrill. 1996. Sphingomyelin consumption suppresses aberrant colonic crypt foci and increases the proportion of adenomas versus adenocarcinomas in CF1 mice treated with 1,2-dimethylhydrazine: implications for dietary sphingolipids and colon carcinogenesis. Cancer Res. 56: 4936-4941.
8. Schmelz, E. M., A. S. Bushnev, D. L. Dillehay, D. C. Liotta, and A. H. Merrill. 1997. Suppression of aberrant colonic crypt foci by synthetic sphingomyelins with saturated or unsaturated sphingoid base backbones. Nutr. Cancer. 28: 81-85.
9. Ahn, E. H., and J. J. Schroeder. 2002. Sphingoid bases and ceramide induce apoptosis in HT-29 and HCT-116 human colon cancer cells. Exp. Biol. Med. 227: 345-353.
10. Schmelz, E. M., P. C. Roberts, E. M. Kustin, L. A. Lemonnier, M. C. Sullards, D. L. Dillehay, and A. H. Merrill. 2001. Modulation of intracellular beta-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids. Cancer Res. 61: 6723-6729.
11. Nilsson, Å. 1969. The presence of sphingomyelin- and ceramide-cleaving enzymes in the small intestinal tract. Biochim. Biophys. Acta. 176: 339-347.
12. Quintern, L. E., E. H. Schuchman, O. Levran, M. Suck, K. Ferlinz, H. Reinke, K. Sandhoff, and R. J. Desnick. 1989. Isolation of cDNA clones encoding human acid sphingomyelinase: occurrence of alternatively processed transcripts. EMBO J. 8: 2469-2473.
13. Chatterjee, S., H. Han, S. Rollins, and T. Cleveland. 1999. Molecular cloning, characterization, and expression of a novel human neutral sphingomyelinase. J. Biol. Chem. 274: 37407-37412.
14. Duan, R-D., E. Hertervig, L. Nyberg, T. Tauge, B. Sternby, J. Lillienau, A. Farooqi, and A. Nilsson. 1996. Distribution of alkaline sphingomyelinase activity in human beings and animals. Dig. Dis. Sci. 41: 1801-1806.
15. Nyberg, L., R-D. Duan, J. Axelsson, and A. Nilsson. 1996. Identification of an alkaline sphingomyelinase activity in human bile. Biochim. Biophys. Acta. 1300: 42-48.
16. Cheng, Y., Å. Nilsson, E. Tömquist, and R-D. Duan. 2002. Purification, characterization and expression of rat intestinal alkaline sphingomyelinase. J. Lipid Res. 43: 316-324.
17. Nyberg, L., Å. Nilsson, P. Lundgren, and R-D. Duan. 1997. Localization and capacity of sphingomyelin digestion in the rat intestinal tract. J. Nutr. Biochem. 8: 112-118.
18. Hertervig, E., Å. Nilsson, L. Nyberg, and R-D. Duan. 1996. Alkaline sphingomyelinase activity is decreased in human colorectal carcinoma. Cancer. 79: 448-453.
19. Hertervig, E., Å. Nilsson, J. Björk, R. Hultkrantz, and R-D. Duan. 1999. Familial adenomatous polyposis is associated with a marked decrease in alkaline sphingomyelinase activity: a key factor to the unrestrained cell proliferation. Br. J. Cancer. 81: 232-236.
20. Sjöqvist, U., E. Hertervig, Å. Nilsson, R-D. Duan, A. Ost, B. Tribukait, and R. Lofberg. 2002. Chronic colitis is associated with a reduction of mucosal alkaline sphingomyelinase activity. Inflamm. Bowel Dis. 8: 258-263.
21. Cheng, Y., H-T. Tauschel, Å. Nilsson, and R-D. Duan. 1999. Administration of ursodeoxycholic acid increases the activities of alkaline sphingomyelinase and caspase-3 in rat colon. Scand. J. Gastroenterol. 34: 915-920.
22. Chen, H., E. Born, S. N. Mathur, F. C. Johlin, and F. J. Field. 1992. Sphingomyelin content of intestinal cell membranes regulates cholesterol absorption. Evidence for pancreatic and intestinal cell sphingomyelinase activity. Biochem. J. 286: 771-777.
23. Field, F. J., E. Born, S. Murthy, and S. N. Mathur, 1998. Transport of cholesterol from the endoplasmic reticulum to the plasma membrane is constitutive in CaCo-2 cells and differs from the transport of plasma membrane cholesterol to the endoplasmic reticulum. J. Lipid Res. 39: 333-343.
24. Field, F. J., H. Chen, E. Born, B. Dixon, and S. Mathur. 1993. Release of ceramide after membrane sphingomyelin hydrolysis decreases the basolateral secretion of triacylglycerol and apolipoprotein B in cultured human intestinal cells. J. Clin. Invest. 92: 2609-2619.
25. Kirby, R. J., S. Zheng, P. Tso, P. N. Howles, and D. Y. Hui. 2002. Bile salt-stimulated carboxyl ester lipase influences lipoprotein assembly and secretion in intestine: a process mediated via ceramide hydrolysis. J. Biol. Chem. 277: 4104-4109.
26. Nyberg, L., R-D. Duan, and Å. Nilsson. 2000. A mutual inhibitory effect on absorption of sphingomyelin and cholesterol. J. Nutr. Biochem. 11: 244-249.
27. Eckhardt, E. R., D. Q. Wang, J. M. Donovan, and M. C. Carey. 2002. Dietary sphingomyelin suppresses intestinal cholesterol absorption by decreasing thermodynamic activity of cholesterol monomers. Gastroenterology. 122: 948-956.
28. Stoffel, W. 1975. Chemical synthesis of choline-labeled lacithins and sphingomyelin. Methods Enzymol. 36: 533-541.
29. Duan, R. D., and Å. Nilsson. 1999. Enzymes hydrolysing sphingolipids in gastrointestinal tract. Methods Enzymol. 311: 276-286.
30. Hansen, G. H., L. Immerdal, E. Thorsen, L-L. Niels-Christiansen, B. T. Nystrom, E. J. F. Demant, and E. M. Danielsen. 2001. Lipid rafts exist as stable cholesterol-independent microdomains in the brush border membrane of enterocytes. J. Biol. Chem. 276: 32338-32344.
31. Liu, J-J., Å. Nilsson, S. Oredsson, V. Badmaev, W-Z. Zhao, and R-D. Duan. 2002. Boswellic acids trigger apoptosis via a pathway dependent on caspase-8 activation but independent of Fas/Fas ligand interaction in colon cancer HT29 cells. Carcinogenesis. 23: 2087-2093.
32. Hedlund, M., M. Svensson, Å. Nilsson, R-D. Duan, and C. Svanborg. 1996. Role of the ceramide-signaling pathway in cytokine responses to P-fimbriated Escherichia coli. J. Exp. Med. 183: 1037-1044.
33. Bligh, E. H., and W. J. Dyer. 1959. A rapid method for total lipid extraction and purification. Can J. Biochem. Physiol. 37: 911-918.
34. Duan, R-D., and Å. Nilsson. 1997. Purification of a newly identified alkaline sphingomyelinase in human bile and effects of bile salts and phosphatidylcholine on enzyme activity. Hepatology. 26: 823-830.
35. Duan, R-D., Y. Cheng, H-D. Tauschel, and Å. Nilsson. 1998. Effects of ursodeoxycholate and other bile salts on levels of rat intestinal alkaline sphingomyelinase. A potential implication in tumorigenesis. Dig. Dis. Sci. 43: 26-32.
36. Duan, R-D., L. Nyberg, and Å. Nilsson. 1995. Alkaline sphingomyelinase activity in rat gastrointestinal tract: distribution and characterization. Biochim. Biophys. Acta. 1259: 49-55.
37. Chatterjee, S. 1993. Neutral sphingomyelinase. Adv. Lipid Res. 26: 25-48.
38. Hansen, G. H., E. M. Danielsen, H. Sjöström, and O. Norén. 1989. Organelles involved in the intracellular transport of newly synthesized aminopeptidase N and their acidity. Eur. J. Cell Biol. 49: 154-161.
39. Hansen, G. H., L. L. Niel-Christiansen, M. D. Poulsen, O. Norén, and H. Sjöström. 1994. Distribution of three microvillar enzymes along the small intestinal crypt-villus axis. J. Submicrosc. Cytol. Pathol. 26: 453-460.
40. Yang, L., M. Mutanen, Y. Cheng, and R-D. Duan. 2002. Effects of red meat and fiber in high fat diet on activities of sphingomyelinase, ceramidase and caspase-3 in rat colonic mucosa. J. Nutr. Biochem. 13: 499-504.
41. Earnest, D. L., H. Holubec, R. K. Wali, C. S. Jolley, M. Bissonette, A. K. Bhattacharyya, H. Roy, S. Khare, and T. A. Brasitus. 1994. Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid. Cancer Res. 54: 5071-5074.
42. Colell, A., O. Coll, M. Mari, J. C. Fernandez-Checa, and J. Garcia-Valero. 2002. Divergent role of ceramide generated by exogenous sphingomyelinase on NF-kappa B activation and apoptosis in human colon HT29 cells. FEBS Lett. 526: 15-20.